This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 1988.
Company Filing History:
Years Active: 1988
Title: The Innovations of Derek Burn
Introduction
Derek Burn is a notable inventor based in Chalfont St. Giles, GB. He has made significant contributions to the field of chemistry, particularly in the development of heterocyclic amino compounds. His work has implications for medical science, especially in the area of selective receptor antagonism.
Latest Patents
Derek Burn holds a patent for "Heterocyclic amino compounds." This patent describes compounds of the general formula (I), wherein R can be H, alkyl, alkenyl, alkynyl, cycloalkyl, aralkyl, or CHO. Additionally, R1 and R2 each represent H, fluorine, or chlorine. The compounds exhibit selective α2-adrenoreceptor antagonist action. They can be synthesized through the amination of compounds of the general formula (II), where X is a leaving group. This innovation has the potential to impact therapeutic approaches in various medical conditions.
Career Highlights
Derek Burn is associated with Glaxo Group Limited, a prominent company in the pharmaceutical industry. His work there has allowed him to focus on innovative research and development in drug formulation and design. His patent reflects his commitment to advancing medical science through innovative chemical solutions.
Collaborations
Derek has collaborated with esteemed colleagues such as Peter C Cherry and Adrian J Pipe. These collaborations have likely enriched his research and contributed to the successful development of his patented compounds.
Conclusion
Derek Burn's contributions to the field of chemistry, particularly through his patent on heterocyclic amino compounds, highlight his innovative spirit and dedication to advancing medical science. His work at Glaxo Group Limited and collaborations with other professionals further emphasize the importance of teamwork in achieving groundbreaking results.